We demonstrated that, in distinction to classical opioid receptors, ACKR3 won't induce classical G protein signaling and is not modulated because of the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists including naloxone. Alternatively, we recognized that LIH383, an ACKR3-selective subnanomolar competitor https://johnr692atj0.wikiannouncing.com/user